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Abstract
Background: The tuberculosis (TB) bacillus and the Human Immunodeficiency Virus (HIV) have
formed a powerful alliance and are together responsible for more than five million deaths per year.
TB is leading to increased mortality rates among people living with HIV/acquired immunodeficiency
syndrome (AIDS). The aim of this study was to investigate the geographical and temporal
distribution of TB-HIV deaths in Africa in order to identify possible high-risk areas.
Methods: Time trends in the 16-year study period from 1990 to 2005 were analyzed by multilevel
Poisson growth curve models. Moran global and local indicators of spatial associations were used
to test for evidence of global and local spatial clustering respectively.
Results: Eastern, Southern, Western, and Middle Africa experienced an upward trend in the
number of reported TB-HIV deaths. The spatial distribution of TB cases was non-random and
clustered, with a Moran's I = 0.454 (p = .001). Spatial clustering suggested that 13 countries were
at increased risk of TB-HIV deaths, and six countries could be grouped as "hot spots".
Conclusion: Evidence shows that there is no decline in growth in the number of deaths due to
TB among HIV positive in most Africa countries. There is presence of 'hot-spots' and very large
differences persist between sub-regions. Only by tackling TB and HIV together will progress be
made in reversing the burden of both diseases. There is a great need for scale-up of preventive
interventions such as the World Health Organization '3I's strategy' (intensified case finding,
isoniazid preventive therapy and infection control).
Background
From the early stages of the Human Immunodeficiency
Virus (HIV) epidemic, a strong association with tubercu-
losis (TB) was apparent [1] and HIV subsequently
emerged as one key factor undermining global TB control
[2]. Despite being preventable and treatable, TB remains
the most common life-threatening opportunistic infec-
tion and a leading cause of deaths among people living
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with HIV/AIDS (PLWHA) [3]. In Africa, which has the
highest rates of both diseases, TB is the leading killer of
PLWHA [2,4-7]. Deaths from TB among HIV-positive peo-
ple (henceforth referred to as TB-HIV deaths) have exacted
a huge toll on the worst affected communities in sub-
Saharan Africa [3]. In recent years, the excess HIV-TB mor-
tality has been 1.6-fold greater in women compared with
men [3]. Unprecedented resources have been invested in
HIV/AIDS throughout low-income countries, but without
a concomitant scale-up in basic TB control and without a
concerted response to TB and HIV co-infection. TB now
threatens the successes borne out of that investment. All
advances in the treatment of HIV and TB to date have the
potential to be undermined, or worse, reversed, by the
widespread failure to respond to the dual TB/HIV co-epi-
demic in a coordinated and integrated way.
The challenge facing the TB and HIV control programmes
in Africa is that the disease burden is not homogenous but
varies geographically. Minimizing the risk of TB-HIV
deaths can be assisted by recognizing its geographical dis-
tribution and identifying areas of high risk. Policy makers
and researchers often want to know the distribution of a
disease incidence by geographical region or associated
environmental factors [8]. The ability to map spatial and
temporal variation in disease risk is more important than
ever, given the ever-increasing disease burden in Africa[9].
In this regard, mapping and investigating risk variations
in TB-HIV deaths is an invaluable tool. Furthermore, map-
ping the variation in risk can help improve the targeting of
scarce resources for public health interventions. This
information is useful both for (1) micro-targeting future
programs and (2) identifying locales where progress has
been made to investigate interventional, socio-economic,
and cultural conditions that may have contributed to the
apparent progress. In the context of Sub-Saharan Africa
countries, most research has been largely limited to trend
analysis of prevalence of HIV and incidence of TB. To the
best of our knowledge, there has been no study performed
to date that examined the trend and geographical dispari-
ties in TB-HIV deaths in sub-Saharan Africa. Without
objective information about the current patterns of TB-
HIV deaths, it is difficult to plan substantial public health
programs that could prevent and lead to reduction in TB-
HIV deaths. With the above issues in mind, the objective
of this study was to describe the geographical and tempo-
ral distribution of TB-HIV deaths in Africa in order to
identify countries with unusually high rates.
Methods
Data
This study primarily uses data from the World Health
Organization (WHO) statistical information system to
describe the temporal and spatial variations in TB-HIV
deaths in Africa. The data set includes the estimated
deaths due to TB among HIV positive people reported
between 1991 and 2006 (expressed as rate per 100,000
populations). Estimates are based on annual case notifica-
tions, on special surveys of the prevalence of infection or
disease and on information from deaths (vital) registra-
tion systems. All forms of TB were included. Estimates of
mortality are based on a consultative and analytical proc-
ess and are published annually [10]. Available data differ
from country to country but include case notifications
and death records (from routine surveillance and vital reg-
istration). For further details the readers may go through
the published literature [2,10,11].
Africa Sub-regions
For this study, Africa was divided into five sub-regions
based on a combination of geographic, economic and sci-
entific criteria. The sub-regions are Northern Africa, West-
ern Africa, Middle Africa, Eastern Africa and Southern
Africa.
Estimation of Time Trend
Temporal patterns were displayed by plotting yearly TB-
HIV deaths against year. Time trends in the 16-year study
period from 1991 to 2006 were analyzed by multilevel
Poisson growth curve models. In this two-level model, TB-
HIV deaths for each calendar year referred to level-1 and
the level-2 unit as each country. Time-on-study was mod-
elled as four different time periods, allowing time effects
to be nonlinear. The quartiles were 1991 to 1994 (refer-
ence), 1995 to 1998, 1999 to 2002, and 2003 to 2006.
Time trend may differ across sub-regions. The time-trend
analysis was done in two steps. In the first approach, all
five sub-regions were pooled into one datum set. In the
second model, all five sub-regions were analysed sepa-
rately.
GIS mapping and Smoothing
For conducting a GIS (geographic information system)-
based analysis on the spatial distribution of TB-HIV
deaths, the country-level polygon map was obtained, on
which the country-level point layer containing informa-
tion regarding latitudes and longitudes of central points
of each county was created. All TB-HIV deaths were geoc-
oded and matched to the country-level layers of polygon
and point by administrative code. To alleviate variations
of number of TB-HIV deaths in small populations and
areas, annualized average TB-HIV deaths per 100,000 at
each administrative region over the 16-year period were
calculated [12]. Spatial rate smoothing was carried out
using empirical Bayes approach. Smoothing geographi-
cally-defined data can uncover unexpected features, pat-International Journal of Health Geographics 2009, 8:65 http://www.ij-healthgeographics.com/content/8/1/65
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terns, or gradients that one might not otherwise detect
from a display [13,14]. Geographically-defined data are
often amenable to smoothing, since data in one region are
likely affected, to a greater or lesser extent, by data in
neighbouring regions [13,14]. Smoothing borrows neigh-
bouring information in a flexible way to permit explora-
tory analyses and provide indications of possible patterns
that one might otherwise find difficult to detect [13-16].
In addition, smoothing can reduce attention to unusual
values or outliers [13-16]. Based on annualized average
incidence, all countries were grouped into quartiles-based
categories: non-endemic area (1st quartile); low-endemic
area (2nd quartile); medium-endemic area (3rd quartile);
and high-endemic area (4th quartile). The four categories
of country were colour coded on maps. To assess the risk
of TB-HIV deaths in each country, an excess hazard map
was produced. The map represents the ratio of the
observed number of TB-HIV deaths for each country over
the expected number of TB-HIV deaths. A likelihood func-
tion was used to test for elevated risk within the country
in comparison with risk outside the country. The likeli-
hood function for any given country was proportional to:
where D is the total number of TB-HIV deaths, d is the
number of TB-HIV deaths within the country and n is the
expected number of TB-HIV deaths. The indicator func-
tion I() is 1 when TB-HIV deaths in the country are more
than expected; otherwise it is 0. The excess risk is a non-
spatial measure, which ignores the influence of spatial
autocorrelation [12].
Spatial Autocorrelation Analysis
The Global Moran's I [17] was used as a measure of the
overall clustering and is assessed by a test of a null hypoth-
eses. Rejection of this null hypothesis suggests a spatial
pattern or spatial structure. Spatial connectivity was incor-
porated by a spatial weights matrix "W" [17]. The global
measure of Moran's I is defined as:
where wij is the row-standardized contiguity matrix, xi is
the risk scale measure at country I, and xj is the risk scale
measure at country j, and μ is the average level of risk.
While Moran's I provides a measure of the overall cluster-
ing, it does not show "where the clusters or outliers are
located, nor what type of spatial correlation is most
important (e.g. correlation between high or between low
values)" [18].
Local measures of spatial association provide a measure of
association for each unit and help identify the type of spa-
tial correlation--these are carried out using the Local Indi-
cators of Spatial Association (LISA) [17]. The Local
Moran's I is used as an indicator of local spatial associa-
tion. The local measure of Moran's I is defined as:
The Moran significance map builds on the Moran scatter
plot and incorporates information about the significance
of "local" spatial patterns. The Moran scatter plot helps
identify the nature of spatial autocorrelation between
countries so they can be categorised into four groups. For
the TB-HIV deaths these are:
• High-high: high value of TB-HIV deaths in a country,
neighbouring countries have high values of TB-HIV
deaths (spatial clusters).
￿  Low-high: low value of TB-HIV deaths in a country,
neighbouring countries have high values of TB-HIV
deaths (spatial outliers).
￿ Low-low: low value of TB-HIV deaths in a country, neigh-
bouring countries have low values of TB-HIV deaths (spa-
tial clusters).
￿  High-low: high value of TB-HIV deaths in a country,
neighbouring countries have low values of TB-HIV deaths
(spatial outliers).
After computing the appropriate statistic from the
smoothed rates, a Monte Carlo Randomization (MCR)
procedure was used to recalculate the statistic from the
randomized data observations to generate a reference dis-
tribution using 999 permutations. The p-values were com-
puted by comparing the observed statistic to the
distribution generated by the MCR process and signifi-
cance level was set as .001.
Software
Exploratory spatial data analysis (ESDA) was carried out
through the GeoDa software[19]. GeoDa provides a very
user-friendly environment to implement ESDA methods
and is freely downloadable [20]. Stata versus 10 for Win-
dows was used multilevel Poisson growth curve models
(Stata Corp., College Station, TX, USA).
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Results
Temporal variability
Figure 1 depicts the trends of reported TB-HIV deaths in
the period 1991 to 2006. Eastern Africa ranked first in
absolute upward trend in number of reported TB-HIV
deaths, followed by Southern and Western Africa. Growth
curve analysis confirmed a continual increase in the
number of reported TB-HIV deaths in all African sub-
regions except for Northern Africa (Table 1). Compared to
the reference period (1991 to 1994), incidence risk ratios
(95% confidence interval) in 2003 to 2006 were
6.46(5.69 to 7.35), 2.94(2.50 to 3.46), 2.69(2.24 to
3.22), and 1.37(1.28 to 1.47) for Southern, Western, Mid-
dle, and Eastern Africa, respectively. This equates to a total
increase of 546%, 194%, 169%, and 37% in the TB-HIV
deaths between 1991 - 1994 and 2003-2006. The time-
trend analysis was not significant for Northern Africa.
Spatial Distribution and Autocorrelation
The median annualized average TB-HIV deaths at the
country level was 8.88 (range: 0 to 113.25) per 100,000
population per year. Twelve countries were non-endemic,
with annualized average TB-HIV deaths between zero and
5.50 per 100,000; 12 were low-endemic, with incidence
between 5.50 and 11.50 per 100,000; 12 were medium-
endemic, with incidence between 11.50 and 30.50 per
100,000; and 11 were high-endemic, with incidence
greater than 30.50 per 100,000. The four types of areas
were displayed in the thematic map as shown in Figure 2.
A spatially smoothed percentile map of annualized aver-
age TB-HIV deaths was created; smoothed rate presents a
better pattern and shows clearly where the problem was
most severe (Figure 2). The excess hazard map depicted in
Figure 3 showed distribution of the excess risk, which was
a ratio of the observed number over the expected number
of cases. Countries marked in blue had lower incidences
than expected, as showed by excess risk values less than 1.
In contrast, countries in red and light yellow had inci-
dences higher than expected, with risk values greater than
1. Figure 4 shows results of global spatial autocorrelation
analyses for TB-HIV deaths in Africa from 1991 to 2006.
As shown in figure 4, the value of Global Moran's I
increased from 0.293 in 1991 to 0.553 in 2006. The for-
mal test of spatial dependence was not significant from
1991 to 1996 (p > 0.01). The formal test were significant
at p < .001 for 2001 to 2006 and annualized average.
Thus, we rejected the null hypothesis of spatial independ-
ence and concluded that there was sufficient evidence of
spatial dependence. The results of Local Moran's I show
statistically significance spatial autocorrelation (Moran's I
= 0.454, p = .001) (Figure 5). Southern and some parts of
Eastern Africa belong to High-high (hot-spot) clusters.
These are locations with high TB-HIV deaths with similar
neighbours. The locations marked in blue belong to Low-
low (cold-spot) clusters. These are countries with low TB-
HIV deaths with similar neighbours. The United Republic
of Tanzania is the only country in a Low-high cluster,
potential an outlier. In order words, the United Republic
Temporal trends in HIV-TB deaths, African sub-regions, 1991  to 2006 Figure 1
Temporal trends in HIV-TB deaths, African sub-
regions, 1991 to 2006.
Table 1: Temporal trends in TB cases by sub-regions in Africa, 1991 to 2006
Incidence rate ratio*(95% CI)
1991-1994 1995-1998 1999-20002 2003-2006p-trend
All Africa 1 (reference) 1.78(1.68 to 1.87) 2.35(2.24 to 2.47) 2.24(2.13 to 2.36).000
Sub-regions
Eastern Africa 1 (reference) 1.51(1.42 to 1.61) 1.59(1.49 to 1.69) 1.37(1.28 to 1.47).000
Western Africa 1 (reference) 1.90(1.59 to 2.26) 2.71(1.30 to 3.20) 2.94(2.50 to 3.46).000
Southern Africa 1 (reference) 3.17(2.76 to 3.63) 6.38(5.61 to 7.25) 6.46(5.69 to 7.35).000
Middle Africa 1 (reference) 1.86(1.53 to 2.50) 2.51(2.09 to 3.02) 2.69(2.24 to 3.22).000
Northern Africa 1 (reference) 1.18(0.62 to 2.25) 1.18(0.62 to 2.25) 1.18(0.62 to 2.25).950
*estimates are from Multilevel Poisson growth curve modelsInternational Journal of Health Geographics 2009, 8:65 http://www.ij-healthgeographics.com/content/8/1/65
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of the Tanzania is a country with low TB-HIV deaths and
with high-incidence neighbours. The other countries
marked in white are locations with no statistically signifi-
cant autocorrelation.
Discussion
Temporal variability
We have provided evidence that the number of TB-HIV
deaths increased yearly in Africa except for North Africa.
The observed trends varied markedly across the African
sub-regions, such that Eastern Africa ranked first in abso-
lute upward trend in number of reported TB-HIV deaths,
followed by Southern and Western Africa. The rising trend
in TB-HIV deaths that we observed echoes findings in a
study by Zwang and colleagues[21]. Zwang et al[21]
investigated trends and age-sex patterns of mortality in
PTB/HIV co-infection in a rural population in South
Africa. They found that mortality related to PTB/HIV co-
infection began somewhat earlier among men than
among women, and increased quickly over time[21]. A
similar trend has been reported separately for incidence of
TB [2,22-25] and prevalence of HIV in sub-Saharan
Africa[26]. Rising levels of TB co-infection with HIV in
immigrants from Africa have also been documented in the
literature [27,28]. Ahmed and co-researchers [27] exam-
ined the growing impact of HIV infection on the epidemi-
ology of TB in England and Wales between 1999 and
2003; and found that about six percent of the cases of TB
were co-infected with HIV and there was a yearly increase
in the proportion. In addition, the study provided evi-
dence that patients co-infected with HIV were predomi-
nantly those born abroad. Among cases of TB of black
African origin, women had a higher proportion co-
infected with HIV than men. Velasco and co-researchers
[28] reported that most TB-HIV infected immigrants in
Spain are from Africa.
The unprecedented growth of the TB epidemic in Africa is
attributable to several factors, the most important being
the HIV pandemic. Driven by a generalized HIV epidemic
[2,4,6,7,29] and compounded by weak health care sys-
tems, inadequate laboratories, and conditions that pro-
mote transmission of infection, this devastating situation
has steadily worsened, exacerbated by the emergence of
drug-resistant strains of TB. There were an estimated 1.37
million HIV positive TB patients globally in 2007 [10,30].
Around 80% of patients live in sub-Saharan Africa.
456,000 people died of HIV-associated TB in 2007
[10,30]. At least one-third of the 33.2 million people liv-
ing with HIV worldwide are infected with TB and are 20-
30 times more likely to develop TB than those without
HIV. Without proper treatment, about 90 percent of
PLWHA die within months of developing active TB dis-
ease [31]. With the recent spread of drug-resistant TB, this
already complicated interplay between TB and HIV has
only become more deadly, more costly, and more difficult
Spatially smoothed percentile map of annualized average TB-HIV deaths in Africa, 1991 to 2006 Figure 2
Spatially smoothed percentile map of annualized average TB-HIV deaths in Africa, 1991 to 2006.International Journal of Health Geographics 2009, 8:65 http://www.ij-healthgeographics.com/content/8/1/65
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to address. Because most countries throughout Africa have
little or no capacity to test for TB drug resistance, and also
due to the increased difficulty of treatment and the
already high mortality associated with standard TB-HIV
co-infection, drug-resistant TB has resulted in mortality
rates exceeding 95 percent in PLWHA in some settings
[10,31].
Spatial variability
In the study, exploratory spatial data analysis (ESDA)
methods [17,32] were carried out to study spatial relation-
ship in TB-HIV deaths at country level in Africa. ESDA is
an extension of exploratory data analysis (EDA) that
focuses on detecting spatial patterns in data and the gen-
eration of hypotheses based on the spatial patterns in the
data [33,34]. TB-HIV deaths were mapped from different
aspects such as crude incidence, excess risk and spatially
smoothed incidence. In addition, the study evaluated spa-
tial patterns and highlighted geographic areas with signif-
icantly high TB-HIV deaths in Africa. The study showed
that the spatial distribution of TB-HIV deaths in Africa was
non-random and with evidence of statistically significant
clustering. Through exploratory spatial analyses, the study
was able to pinpoint geographic areas with higher risk and
to assess temporal variability of the risk areas, thus provid-
ing a working hypothesis on risk of TB-HIV deaths and
environmental exposures. Geographic areas with higher
cases of TB need further epidemiologic investigation for
potential relationships between lifetime environmental
exposures and risk of TB-HIV deaths.
Policy implications
Despite the link between the two diseases being acknowl-
edged as far back as the 1980s, efforts to control TB and
HIV/AIDS remain largely independent of each other, an
oversight that has resulted in millions of unnecessary
deaths. Only by tackling TB and HIV together will progress
be made in reversing the burden of both diseases. All
advances in the treatment of HIV/AIDS and TB to date
have the potential to be undermined, or worse, reversed,
by the widespread failure to respond to the TB/HIV co-epi-
demic in a coordinated and collaborative way. To acceler-
ate progress towards epidemiological impact targets set
for 2015, HIV-TB must move up the global public health
agenda with increased resource allocation and concerted
international action. There is a great need for scale-up of
preventive interventions such as the WHO '3I's strategy'.
To finally stop people living with HIV from dying of TB,
there is a need for bold action from all sectors. One such
Excess hazard map of annualized average TB-HIV deaths in Africa, 1991 to 2006 Figure 3
Excess hazard map of annualized average TB-HIV deaths in Africa, 1991 to 2006.International Journal of Health Geographics 2009, 8:65 http://www.ij-healthgeographics.com/content/8/1/65
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strategy would be to screen all PLWHA accessing HIV/
AIDS care for TB and make the "3 Is"--intensified case
finding, infection control, and isoniazid preventive ther-
apy--central to HIV/AIDS services and universally availa-
ble [35]. Affected countries, donors, and technical
agencies must join together to craft a plan to ensure uni-
versal access to high quality TB-HIV care by the year 2015
- moving in coordination with the goal of universal access
on HIV by 2010. Finding and treating TB cases, adminis-
tering antiretroviral therapy (ART) and isoniazid preven-
tive therapy (IPT), and infection control are critical
activities to incorporate into HIV care programs. Because
patients with HIV are at risk for TB throughout life, activ-
ities should be ongoing in paediatric and adult ART clin-
ics, pre-ART clinics (keeping relatively healthy patients
engaged in care), and maternal health programs
Conclusion
This study has shown the presence of hot spots of TB-HIV
deaths in Africa and continued upward trend in TB-HIV
mortality, providing more information on priority areas
for public health planning and resource allocation for pre-
venting TB. The study has also demonstrated that using
existing health data, GIS and GIS-based spatial statistical
techniques could provide an opportunity to clarify and
quantify the health burden from TB-HIV deaths within
highly endemic areas and also lay a foundation to pursue
further investigation into the environmental factors
responsible for increased disease risk.
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